Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2003
10/16/2003WO2003037159A3 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003035790A3 Improved method for generating an aerosol
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003026626A3 Modified release dosage forms
10/16/2003WO2003015707A3 Method for treating lung cancers
10/16/2003WO2003015494A3 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/16/2003WO2003013427A3 A method for preparing fluticasone derivatives
10/16/2003WO2003011314A3 Use of lhrh-antagonists for the improvement of t-cell mediated immunity
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002085299A3 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/16/2003WO2002080884A3 Powder inhaler formulations
10/16/2003WO2002064134A3 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies
10/16/2003WO2002055101A9 Storage stable powder compositions of interleukin-4 receptor
10/16/2003WO2001089527A3 Pharmaceutical composition comprising loratadine and a nasal decongestant
10/16/2003US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof
10/16/2003US20030195257 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195232 2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195215 Compounds effective as beta-2 adrenoreceptor agonists as well pde4-inhibitors
10/16/2003US20030195214 Cancer treatment
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/16/2003US20030195181 Laulimalide derivatives
10/16/2003US20030195179 Redispersibility comprising polyvinylpyrrolidone and a water-soluble anionic macromolecular compound which are added to prevent a hardly soluble drug from adhering to a container and forming aggregates
10/16/2003US20030195172 Novel phosphonic acid compounds as inhibitors of serine proteases
10/16/2003US20030195169 Such as (S)-phosphoric acid mono-(3-(5-chloro-2-methoxy-phenyl)-3-fluoro-2-oxso-6-trifluoromethyl-2,3 -dihydro-indol-1-ylmethyl)ester; for modulation of large-conductance calcium-activated potassium (BK) channels
10/16/2003US20030195168 Comprises macrocyclic diterpene compounds from Euphorbiaceae for treatment and prophylaxis of protein kinase C (PKC) related conditions (alcoholism, Alzheimer's disease, asthma, atherosclerosis); expression inhibition; computer programs
10/16/2003US20030195160 Sodium channel blockers
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194456 Extract of the leaves and/or stem of Argemone mexicana plant for treatment of psoriasis and related biochemical and immunological disorders
10/16/2003US20030194452 Improved herbal composition having antiallergic properties and a process for the preparation thereof
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003US20030194391 Vaccine
10/16/2003US20030194378 Novel aerosol formulation containing a polar fluorinated molecule
10/16/2003US20030192551 Methods and devices for use in performing pulmonary procedures
10/16/2003US20030192550 Methods and devices for use in performing pulmonary procedures
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/16/2003CA2481850A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003CA2481463A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2481028A1 Hormone replacement therapy
10/16/2003CA2480818A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003CA2480790A1 Use of antithrombin iii in treating acute lung injury
10/16/2003CA2480482A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
10/16/2003CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003CA2480082A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003CA2479522A1 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003CA2479520A1 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003CA2478934A1 Process for producing oil and fat composition containing hydrophobic components of glycyrrhiza
10/16/2003CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352659A1 Combination drugs
10/15/2003EP1352646A2 Lozenge containing ambroxol
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351973A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
10/15/2003EP1351962A2 Thienopyrimidine
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351704A2 Storage stable powder compositions of interleukin-4 receptor
10/15/2003EP1351688A1 Urotensin-ii receptor antagonists
10/15/2003EP1351687A2 Urotensin-ii receptor antagonists
10/15/2003EP1351686A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/15/2003EP1268471B1 N-heterocyclic derivatives as nos inhibitors
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1212316B1 Benzopyrans and benzothiopyrans as rar selective retinoid agonists
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP1005332B1 Pharmaceutical composition for reducing production of mcp-1 protein
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003CN1449446A Streptococcus antigens
10/15/2003CN1449396A Carbamates derived from arylalkylamines
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/15/2003CN1449377A Inhibitors of alpha4 mediated cell adhesion
10/15/2003CN1449288A Pharmaceutical formulation of salmeterol and fluticasone propionate
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1449285A Use of il-8 receptor antagonists in the treatment of virus infections
10/15/2003CN1449278A Lung surfactant compositions with dynamic swelling behaviour
10/15/2003CN1448179A Application of bicoptis for injection in preparation of medicine for curing serious acute respiratory tract syndrome
10/15/2003CN1448173A Cymose buckwheat rhizome preparation,production method and use thereof
10/15/2003CN1448169A Traditional Chinese medicine for treating chronic trachitis, and method for preparing same
10/15/2003CN1448131A Medicine composition containing alpha-pinene and 1,8-eucalyptol fever-tree oil and use thereof
10/15/2003CN1448081A Pear, peach and apricot honey sugar slab for prevention and cure of cough and asthma